Ippei Fukada
6PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 07, 2024
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study.Yosuke Aoyama, Yukinori Ozaki, Rika Kizawa
|Oct 20, 2023
Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice.Ippei Fukada, Seiichi Mori, Naomi Hayashi
|Mar 22, 2022
Assessment of a cancer genomic profile test for patients with metastatic breast cancer.Ippei Fukada, Seiichi Mori, Naomi Hayashi
|Sep 23, 2021
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17).Ippei Fukada, Yoshinori Ito, Naoto Kondo
|Sep 13, 2017
The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.Ippei Fukada, Yoshinori Ito, Kokoro Kobayashi
Pageof 1
Frequent Collaborators
3 joint publications
Takayuki Ueno
2 joint publications
Yosuke Aoyama
2 joint publications
Yukinori Ozaki
2 joint publications
Nami Yamashita
2 joint publications
Meiko Nishimura
2 joint publications
Toshimi Takano
1 joint publications
Norikazu Masuda
1 joint publications
Kazuma Kiyotani
1 joint publications
Rika Kizawa
1 joint publications
Masahiro Kuno